P. Rudolph

864 total citations
28 papers, 697 citations indexed

About

P. Rudolph is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, P. Rudolph has authored 28 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in P. Rudolph's work include Sarcoma Diagnosis and Treatment (6 papers), Neuroblastoma Research and Treatments (4 papers) and Cutaneous Melanoma Detection and Management (4 papers). P. Rudolph is often cited by papers focused on Sarcoma Diagnosis and Treatment (6 papers), Neuroblastoma Research and Treatments (4 papers) and Cutaneous Melanoma Detection and Management (4 papers). P. Rudolph collaborates with scholars based in Germany, United States and Sweden. P. Rudolph's co-authors include Reza Parwaresch, Udo Kellner, Enno Christophers, D. Schmidt, Axel Hauschild, Winfried Brenner, Regine Gläser, E. Henze, M. L. Hansmann and Hans Kreipe and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

In The Last Decade

P. Rudolph

27 papers receiving 672 citations

Peers

P. Rudolph

ONCOL

PRM

IMMUN

Kim Ow Australia

Rebecca Ruhl United States

Naotake Tanaka Japan

Takehiro Nohara Japan

Tsui‐Lien Mao Taiwan

Bin Fan United States

Marta Krašovec Slovenia

Salim Yazji United States

Ariane Aigelsreiter Austria

Fumio Kataoka Japan

Kim Ow Australia

P. Rudolph

325 ×1.0

220 ×0.7

ONCOL

66 ×0.4

114 ×0.9

PRM

60 ×0.6

IMMUN

Citations per year, relative to P. Rudolph P. Rudolph (= 1×) peers Kim Ow

Countries citing papers authored by P. Rudolph

Since Specialization

Citations

This map shows the geographic impact of P. Rudolph's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Rudolph with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Rudolph more than expected).

Fields of papers citing papers by P. Rudolph

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Rudolph. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Rudolph. The network helps show where P. Rudolph may publish in the future.

Co-authorship network of co-authors of P. Rudolph

This figure shows the co-authorship network connecting the top 25 collaborators of P. Rudolph. A scholar is included among the top collaborators of P. Rudolph based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Rudolph. P. Rudolph is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rudolph, P., et al.. (2012). Medizinisches Versorgungszentrum - geeignetes Instrument der ambulanten patientenadäquaten Versorgung und leistungsgerechten Vergütung. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 138(1). 45–52. 6 indexed citations

Görögh, Tibor, P. Rudolph, J. Hedderich, et al.. (2007). Selective upregulation and amplification of the lysyl oxidase like‐4 (LOXL4) gene in head and neck squamous cell carcinoma. The Journal of Pathology. 212(1). 74–82. 36 indexed citations

Krams, Matthias, P. Rudolph, & D. Harms. (2004). Proliferationskinetik und hTERT-Expression beim Neuroblastom. Der Pathologe. 25(4). 317–23. 1 indexed citations

Gieseler, Frank, et al.. (2003). Resistance mechanisms of gastrointestinal cancers: why does conventional chemotherapy fail?. International Journal of Colorectal Disease. 18(6). 470–480. 28 indexed citations

MacGrogan, Gaëtan, P. Rudolph, I. de Mascarel, et al.. (2003). DNA topoisomerase IIα expression and the response to primary chemotherapy in breast cancer. British Journal of Cancer. 89(4). 666–671. 78 indexed citations

Rudolph, P.. (2002). Melanozyt�re Tumoren. Der Pathologe. 23(1). 89–96. 2 indexed citations

Rudolph, P.. (2002). Der dysplastische Nävus. Der Pathologe. 23(2). 128–134. 4 indexed citations

Kellner, Udo, P. Rudolph, & Reza Parwaresch. (2000). Human DNA-Topoisomerases – Diagnostic and Therapeutic Implications for Cancer. Oncology Research and Treatment. 23(5). 424–430. 39 indexed citations

Papadopoulos, I. & P. Rudolph. (1999). Primary Renal Malignant Fibrous Histiocytoma. Urologia Internationalis. 63(2). 136–138. 14 indexed citations

10.

Rudolph, P., et al.. (1999). Proliferation marker Ki-S11 - a prognostic indicator for squamous cell carcinoma of the hypopharynx. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 435(6). 590–595. 15 indexed citations

11.

Hauschild, Axel, Winfried Brenner, P. Rudolph, et al.. (1999). Prognostic significance of serum S100B detection compared with routine blood parameters in advanced metastatic melanoma patients. Melanoma Research. 9(2). 155–162. 85 indexed citations

12.

Rudolph, P., Christian Dworeck, H J Heidebrecht, et al.. (1999). Immunoenzymatic detection of the new proliferation associated protein p100 by means of a cellular ELISA: specific detection of cells in cell cycle phases S, G2 and M. Journal of Immunological Methods. 223(2). 147–153. 11 indexed citations

13.

Rudolph, P., Per Alm, H J Heidebrecht, et al.. (1999). Immunologic Proliferation Marker Ki-S2 as Prognostic Indicator for Lymph Node-Negative Breast Cancer. JNCI Journal of the National Cancer Institute. 91(3). 271–278. 63 indexed citations

14.

Rudolph, P., F. Bonichon, F. Collin, et al.. (1998). Comparative analysis of prognostic indicators for sarcomas of the soft parts and the viscerae.. PubMed. 82. 246–52. 10 indexed citations

15.

Tronnier, Michael, et al.. (1997). One single erythemagenic UV irradiation is more effective in increasing the proliferative activity of melanocytes in melanocytic naevi compared with fractionally applied high doses. British Journal of Dermatology. 137(4). 534–539. 26 indexed citations

16.

Papadopoulos, I., et al.. (1997). VALUE OF P53 EXPRESSION, CELLULAR PROLIFERATION AND DNA CONTENT AS PROGNOSTIC INDICATOR IN RCC. 32(1). 110–117. 1 indexed citations

17.

Rudolph, P., Barbara Hero, Frank Berthold, et al.. (1997). Prognostic significance of the proliferative activity in neuroblastoma.. PubMed. 150(1). 133–45. 33 indexed citations

18.

Rudolph, P., et al.. (1997). Value of p53 Expression, CellularProliferation, and DNA Content asPrognostic Indicators in Renal CellCarcinoma. European Urology. 32(1). 110–117. 18 indexed citations

19.

Rudolph, P., et al.. (1996). The Cell Cycle – Theory and Application to Cancer. Oncology Research and Treatment. 19(6). 464–472. 29 indexed citations

20.

Rudolph, P., et al.. (1993). Expression of CD 30 and nerve growth factor‐receptor in neoplastic and reactive vascular lesions: an immunohistochemical study. Histopathology. 23(2). 173–178. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact